# OPC5: Pressurized IntraThoracic Aerosol Chemotherapy (PITAC) in Patients With Malignant Pleural Effusion.

> **NCT06421610** · PHASE1 · RECRUITING · sponsor: **Odense University Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Malignant Pleural Effusion
- Pleural Neoplasms
- Quality of Life
- Chemotherapy Effect
- Chemotherapeutic Toxicity
- Pleural Carcinomatosis
- Pleural Cavity Effusion

## Interventions

- **DRUG:** PITAC

## Key facts

- **NCT ID:** NCT06421610
- **Lead sponsor:** Odense University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-09-15
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2024-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06421610

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06421610, "OPC5: Pressurized IntraThoracic Aerosol Chemotherapy (PITAC) in Patients With Malignant Pleural Effusion.". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06421610. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*